Carregant...
The Anti-Factor Xa Range For Low Molecular Weight Heparin Thromboprophylaxis
Low molecular weight heparins (LMWHs) are now the mainstay option in the prevention and treatment of venous thromboembolism. In some patients receiving therapeutic doses of LMWH, activity can be measured by quantifying the presence of Anti-factor Xa (AFXa) for dose adjustment. However, currently the...
Guardat en:
| Publicat a: | Hematol Rep |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
PAGEPress Publications, Pavia, Italy
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4691677/ https://ncbi.nlm.nih.gov/pubmed/26733269 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4081/hr.2015.5844 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|